XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.54−0.08 (-4.94%)
Close on Nov 18, 2026Market cap $14.57MP/E –Yield –
XTL Biopharmaceuticals shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
XTL Biopharmaceuticals's shares outstanding was 545M at Jun 30, 2022. For fiscal 2025 it was 896M, up 33.2% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is 896M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 896M | +33.2% |
| FY2024 | Dec 31, 2024 | 673M | +23.5% |
| FY2023 | Dec 31, 2023 | 545M | -0.0% |
| FY2022 | Dec 31, 2022 | 545M | -11.5% |
| FY2021 | Dec 31, 2021 | 616M | +19.7% |
| FY2020 | Dec 31, 2020 | 514M | 0.0% |
| FY2019 | Dec 31, 2019 | 514M | 0.0% |
| FY2018 | Dec 31, 2018 | 514M | +9.4% |
| FY2017 | Dec 31, 2017 | 470M | +71.6% |
| FY2016 | Dec 31, 2016 | 274M | +3.9% |
| FY2015 | Dec 31, 2015 | 264M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | 545M | – |
| Q2 FY2021 | Jun 30, 2021 | 528M | – |
| Q2 FY2020 | Jun 30, 2020 | 514M | – |
See a number that looks wrong?